Table 2.
Time–effect relationship of ODP on AST, ALT, and ALP in the liver of mice.
| Group/Time | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | |
|---|---|---|---|---|---|---|
| AST (U/L) |
NC | 42.51 ± 3.78 | 42.80 ± 1.52 | 48.56 ± 5.36 | 44.97 ± 6.99 | 47.94 ± 3.98 |
| MC | 47.07 ± 5.16 | 49.31 ± 6.31 * | 61.48 ± 6.32 ** | 53.87 ± 8.98 ** | 57.20 ± 3.61 ** | |
| YC | 45.45 ± 4.75 | 45.14 ± 4.64 | 58.05 ± 6.46 # | 50.73 ± 5.96 # | 48.63 ± 4.85 ## | |
| ODPC | 45.07 ± 3.57 | 42.57 ± 6.91 | 57.28 ± 4.19 # | 45.81 ± 2.98 ## | 49.49 ± 5.99 ## | |
| ALT (U/L) |
NC | 47.45 ± 3.2 | 50.21 ± 3.36 | 46.24 ± 4.36 | 44.18 ± 3.01 | 45.92 ± 2.62 |
| MC | 53.76 ± 2.19 * | 56.04 ± 8.91 * | 67.33 ± 7.41 ** | 62.53 ± 4.13 ** | 63.84 ± 5.73 ** | |
| YC | 50.91 ± 4.93 | 52.35 ± 6.33 | 52.73 ± 6.44 # | 52.93 ± 2.23 # | 49.74 ± 6.86 ## | |
| ODPC | 50.49 ± 7.91 | 52.07 ± 5.43 | 51.45 ± 8.80 # | 45.58 ± 6.85 ## | 47.17 ± 3.82 ## | |
| ALP (U/L) |
NC | 5.22 ± 0.64 | 5.1 ± 0.38 | 4.79 ± 0.39 | 5.55 ± 0.25 | 4.80 ± 0.55 |
| MC | 5.50 ± 1.42 | 6.13 ± 0.76 ** | 6.62 ± 0.47 ** | 6.74 ± 1.19 ** | 6.38 ± 0.52 ** | |
| YC | 5.37 ± 1.05 | 5.30 ± 0.55 # | 5.62 ± 0.64 # | 5.85 ± 0.31 # | 5.57 ± 0.58 # | |
| ODPC | 5.30 ± 0.91 | 5.34 ± 0.31 # | 5.55 ± 0.92 # | 5.40 ± 0.40 ## | 5.02 ± 0.33 ## |
NC: normal control group, MC: CdCl2-treated group, YC: positive-treated group, ODPC: ODP-treated group. * Compared with normal control group (NC group), # compared with model control group (MC group). * p < 0.05, ** p < 0.01; # p < 0.05, ## p < 0.01.